New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:33 EDTIMGNImmunoGen says T-DM1 marketing application under review in U.S, Europe
ImmunoGen expects to reports clinical findings for three compounds and expects to advance its fourth compound, IMGN289, into clinical testing.
News For IMGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 6, 2015
07:26 EDTIMGNCredit Suisse to hold a conference
Antibody Day 2015 to be held in New York on May 6.
April 24, 2015
06:35 EDTIMGNImmunoGen lowers FY15 revenue view to $85M-$95M from $100M-$105M
Consensus for FY15 revenue is $101.12M. Backs FY15 net loss view of $60M-$65M. Raises FY15 cash and cash equivalents at June 30 to $265M-$275M from $75M-$85M.
06:32 EDTIMGNImmunoGen reports Q3 EPS (25c), consensus (24c)
Reports Q3 revenue $11.4M, consensus $20.95M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use